ES2875327T3 - Producción de oligosacáridos - Google Patents
Producción de oligosacáridos Download PDFInfo
- Publication number
- ES2875327T3 ES2875327T3 ES13183670T ES13183670T ES2875327T3 ES 2875327 T3 ES2875327 T3 ES 2875327T3 ES 13183670 T ES13183670 T ES 13183670T ES 13183670 T ES13183670 T ES 13183670T ES 2875327 T3 ES2875327 T3 ES 2875327T3
- Authority
- ES
- Spain
- Prior art keywords
- lacto
- oligosaccharide
- glucosidase
- host microorganism
- beta
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000002482 oligosaccharides Chemical class 0.000 title claims abstract description 128
- 229920001542 oligosaccharide Polymers 0.000 title claims abstract description 125
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 40
- 244000005700 microbiome Species 0.000 claims abstract description 76
- 102000004366 Glucosidases Human genes 0.000 claims abstract description 55
- 108010056771 Glucosidases Proteins 0.000 claims abstract description 55
- 238000000034 method Methods 0.000 claims abstract description 55
- 150000001720 carbohydrates Chemical class 0.000 claims abstract description 35
- 239000000758 substrate Substances 0.000 claims abstract description 23
- 239000000543 intermediate Substances 0.000 claims abstract description 16
- 235000020256 human milk Nutrition 0.000 claims abstract description 11
- 239000006227 byproduct Substances 0.000 claims abstract description 10
- 210000004251 human milk Anatomy 0.000 claims abstract description 10
- 230000001851 biosynthetic effect Effects 0.000 claims abstract description 8
- 108090000623 proteins and genes Proteins 0.000 claims description 36
- 108010005774 beta-Galactosidase Proteins 0.000 claims description 33
- 102000005936 beta-Galactosidase Human genes 0.000 claims description 32
- 102000004169 proteins and genes Human genes 0.000 claims description 32
- SHZGCJCMOBCMKK-DHVFOXMCSA-N L-fucopyranose Chemical compound C[C@@H]1OC(O)[C@@H](O)[C@H](O)[C@@H]1O SHZGCJCMOBCMKK-DHVFOXMCSA-N 0.000 claims description 29
- 230000006652 catabolic pathway Effects 0.000 claims description 27
- 150000002772 monosaccharides Chemical class 0.000 claims description 25
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims description 24
- 230000008569 process Effects 0.000 claims description 20
- 241000588724 Escherichia coli Species 0.000 claims description 17
- 229930182830 galactose Natural products 0.000 claims description 17
- 239000000047 product Substances 0.000 claims description 17
- 235000000346 sugar Nutrition 0.000 claims description 13
- 239000006228 supernatant Substances 0.000 claims description 12
- PNNNRSAQSRJVSB-SLPGGIOYSA-N Fucose Natural products C[C@H](O)[C@@H](O)[C@H](O)[C@H](O)C=O PNNNRSAQSRJVSB-SLPGGIOYSA-N 0.000 claims description 11
- 230000015556 catabolic process Effects 0.000 claims description 11
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 9
- 238000006731 degradation reaction Methods 0.000 claims description 9
- 229950006780 n-acetylglucosamine Drugs 0.000 claims description 9
- 102000012086 alpha-L-Fucosidase Human genes 0.000 claims description 8
- 108010061314 alpha-L-Fucosidase Proteins 0.000 claims description 8
- 241000894006 Bacteria Species 0.000 claims description 7
- 102000002464 Galactosidases Human genes 0.000 claims description 7
- 108010093031 Galactosidases Proteins 0.000 claims description 7
- -1 beta-fucosidase Proteins 0.000 claims description 7
- 102000005348 Neuraminidase Human genes 0.000 claims description 5
- 108010006232 Neuraminidase Proteins 0.000 claims description 5
- 238000010924 continuous production Methods 0.000 claims description 4
- 230000002018 overexpression Effects 0.000 claims description 4
- 230000037361 pathway Effects 0.000 claims description 4
- 150000008163 sugars Chemical class 0.000 claims description 4
- 241000186226 Corynebacterium glutamicum Species 0.000 claims description 3
- 241000235088 Saccharomyces sp. Species 0.000 claims description 3
- 102100032487 Beta-mannosidase Human genes 0.000 claims description 2
- 241000186660 Lactobacillus Species 0.000 claims description 2
- 102100024295 Maltase-glucoamylase Human genes 0.000 claims description 2
- 108010054377 Mannosidases Proteins 0.000 claims description 2
- 102000001696 Mannosidases Human genes 0.000 claims description 2
- QUOQJNYANJQSDA-MHQSSNGYSA-N Sialyllacto-N-tetraose a Chemical compound O1C([C@H](O)[C@H](O)CO)[C@H](NC(=O)C)[C@@H](O)C[C@@]1(C(O)=O)O[C@@H]1[C@@H](O)[C@H](OC2[C@H]([C@H](OC3[C@H]([C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]3O)O)O[C@H](CO)[C@H]2O)NC(C)=O)O[C@H](CO)[C@@H]1O QUOQJNYANJQSDA-MHQSSNGYSA-N 0.000 claims description 2
- 102000005840 alpha-Galactosidase Human genes 0.000 claims description 2
- 108010030291 alpha-Galactosidase Proteins 0.000 claims description 2
- 108010028144 alpha-Glucosidases Proteins 0.000 claims description 2
- 108010012864 alpha-Mannosidase Proteins 0.000 claims description 2
- 102000019199 alpha-Mannosidase Human genes 0.000 claims description 2
- 238000010923 batch production Methods 0.000 claims description 2
- 102000006995 beta-Glucosidase Human genes 0.000 claims description 2
- 108010047754 beta-Glucosidase Proteins 0.000 claims description 2
- 108010055059 beta-Mannosidase Proteins 0.000 claims description 2
- 239000008188 pellet Substances 0.000 claims description 2
- SFMRPVLZMVJKGZ-JRZQLMJNSA-N Sialyllacto-N-tetraose b Chemical compound O1[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(=O)C)[C@@H](O)C[C@@]1(C(O)=O)OC[C@@H]1[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](NC(C)=O)[C@H](O[C@@H]2[C@H]([C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]2O)O)O1 SFMRPVLZMVJKGZ-JRZQLMJNSA-N 0.000 claims 1
- 238000012258 culturing Methods 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 description 42
- 230000004151 fermentation Effects 0.000 description 42
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 36
- 239000008101 lactose Substances 0.000 description 36
- OVRNDRQMDRJTHS-RTRLPJTCSA-N N-acetyl-D-glucosamine Chemical compound CC(=O)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-RTRLPJTCSA-N 0.000 description 28
- 239000002609 medium Substances 0.000 description 28
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 description 25
- MBLBDJOUHNCFQT-LXGUWJNJSA-N N-acetylglucosamine Natural products CC(=O)N[C@@H](C=O)[C@@H](O)[C@H](O)[C@H](O)CO MBLBDJOUHNCFQT-LXGUWJNJSA-N 0.000 description 25
- 238000004128 high performance liquid chromatography Methods 0.000 description 19
- 238000003786 synthesis reaction Methods 0.000 description 19
- 230000015572 biosynthetic process Effects 0.000 description 17
- 210000004027 cell Anatomy 0.000 description 17
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 15
- 230000014509 gene expression Effects 0.000 description 15
- 102000004190 Enzymes Human genes 0.000 description 13
- 108090000790 Enzymes Proteins 0.000 description 13
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 13
- KBGAYAKRZNYFFG-BOHATCBPSA-N aceneuramic acid Chemical compound OC(=O)C(=O)C[C@H](O)[C@@H](NC(=O)C)[C@@H](O)[C@H](O)[C@H](O)CO KBGAYAKRZNYFFG-BOHATCBPSA-N 0.000 description 13
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 13
- 150000007523 nucleic acids Chemical class 0.000 description 11
- AXQLFFDZXPOFPO-UHFFFAOYSA-N UNPD216 Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC(C1O)C(O)C(CO)OC1OC1C(O)C(O)C(O)OC1CO AXQLFFDZXPOFPO-UHFFFAOYSA-N 0.000 description 10
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 9
- 230000001580 bacterial effect Effects 0.000 description 8
- AXQLFFDZXPOFPO-UNTPKZLMSA-N beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-beta-D-Glcp Chemical compound O([C@@H]1O[C@H](CO)[C@H](O)[C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H]([C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)NC(=O)C)[C@H]1[C@H](O)[C@@H](O)[C@H](O)O[C@@H]1CO AXQLFFDZXPOFPO-UNTPKZLMSA-N 0.000 description 8
- USIPEGYTBGEPJN-UHFFFAOYSA-N lacto-N-tetraose Natural products O1C(CO)C(O)C(OC2C(C(O)C(O)C(CO)O2)O)C(NC(=O)C)C1OC1C(O)C(CO)OC(OC(C(O)CO)C(O)C(O)C=O)C1O USIPEGYTBGEPJN-UHFFFAOYSA-N 0.000 description 8
- 239000000203 mixture Substances 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- 235000014633 carbohydrates Nutrition 0.000 description 7
- 239000013598 vector Substances 0.000 description 7
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 description 6
- 230000009471 action Effects 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 230000002255 enzymatic effect Effects 0.000 description 6
- 230000007062 hydrolysis Effects 0.000 description 6
- 238000006460 hydrolysis reaction Methods 0.000 description 6
- 230000000813 microbial effect Effects 0.000 description 6
- 108091028043 Nucleic acid sequence Proteins 0.000 description 5
- 230000008901 benefit Effects 0.000 description 5
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- 239000005017 polysaccharide Substances 0.000 description 5
- 150000004804 polysaccharides Chemical class 0.000 description 5
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- 238000009825 accumulation Methods 0.000 description 4
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 4
- 108010085377 beta-N-Acetylhexosaminidases Proteins 0.000 description 4
- 102000007478 beta-N-Acetylhexosaminidases Human genes 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 230000002950 deficient Effects 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 101150066555 lacZ gene Proteins 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 235000013619 trace mineral Nutrition 0.000 description 4
- 239000011573 trace mineral Substances 0.000 description 4
- SNFSYLYCDAVZGP-OLAZETNGSA-N 2'-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)O[C@H](CO)[C@H](O)[C@@H]1O SNFSYLYCDAVZGP-OLAZETNGSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- LQEBEXMHBLQMDB-UHFFFAOYSA-N GDP-L-fucose Natural products OC1C(O)C(O)C(C)OC1OP(O)(=O)OP(O)(=O)OCC1C(O)C(O)C(N2C3=C(C(N=C(N)N3)=O)N=C2)O1 LQEBEXMHBLQMDB-UHFFFAOYSA-N 0.000 description 3
- LQEBEXMHBLQMDB-JGQUBWHWSA-N GDP-beta-L-fucose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@@H]1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C3=C(C(NC(N)=N3)=O)N=C2)O1 LQEBEXMHBLQMDB-JGQUBWHWSA-N 0.000 description 3
- 102000004157 Hydrolases Human genes 0.000 description 3
- 108090000604 Hydrolases Proteins 0.000 description 3
- SHZGCJCMOBCMKK-PQMKYFCFSA-N L-Fucose Natural products C[C@H]1O[C@H](O)[C@@H](O)[C@@H](O)[C@@H]1O SHZGCJCMOBCMKK-PQMKYFCFSA-N 0.000 description 3
- 102100040648 L-fucose kinase Human genes 0.000 description 3
- 229910004619 Na2MoO4 Inorganic materials 0.000 description 3
- 229910003424 Na2SeO3 Inorganic materials 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- SNFSYLYCDAVZGP-UHFFFAOYSA-N UNPD26986 Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(OC(O)C(O)C2O)CO)OC(CO)C(O)C1O SNFSYLYCDAVZGP-UHFFFAOYSA-N 0.000 description 3
- FRHBOQMZUOWXQL-UHFFFAOYSA-L ammonium ferric citrate Chemical compound [NH4+].[Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FRHBOQMZUOWXQL-UHFFFAOYSA-L 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 3
- 239000004327 boric acid Substances 0.000 description 3
- 229910052799 carbon Inorganic materials 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 3
- 235000019797 dipotassium phosphate Nutrition 0.000 description 3
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 229960004642 ferric ammonium citrate Drugs 0.000 description 3
- 108010083136 fucokinase Proteins 0.000 description 3
- 239000004313 iron ammonium citrate Substances 0.000 description 3
- 235000000011 iron ammonium citrate Nutrition 0.000 description 3
- IEQCXFNWPAHHQR-UHFFFAOYSA-N lacto-N-neotetraose Natural products OCC1OC(OC2C(C(OC3C(OC(O)C(O)C3O)CO)OC(CO)C2O)O)C(NC(=O)C)C(O)C1OC1OC(CO)C(O)C(O)C1O IEQCXFNWPAHHQR-UHFFFAOYSA-N 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- LGQLOGILCSXPEA-UHFFFAOYSA-L nickel sulfate Chemical compound [Ni+2].[O-]S([O-])(=O)=O LGQLOGILCSXPEA-UHFFFAOYSA-L 0.000 description 3
- 229910000363 nickel(II) sulfate Inorganic materials 0.000 description 3
- MGFYIUFZLHCRTH-UHFFFAOYSA-N nitrilotriacetic acid Chemical compound OC(=O)CN(CC(O)=O)CC(O)=O MGFYIUFZLHCRTH-UHFFFAOYSA-N 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 108090000765 processed proteins & peptides Proteins 0.000 description 3
- 239000011684 sodium molybdate Substances 0.000 description 3
- 235000015393 sodium molybdate Nutrition 0.000 description 3
- TVXXNOYZHKPKGW-UHFFFAOYSA-N sodium molybdate (anhydrous) Chemical compound [Na+].[Na+].[O-][Mo]([O-])(=O)=O TVXXNOYZHKPKGW-UHFFFAOYSA-N 0.000 description 3
- 239000011781 sodium selenite Substances 0.000 description 3
- 235000015921 sodium selenite Nutrition 0.000 description 3
- 241000894007 species Species 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 3
- 229910000368 zinc sulfate Inorganic materials 0.000 description 3
- 239000011686 zinc sulphate Substances 0.000 description 3
- 235000009529 zinc sulphate Nutrition 0.000 description 3
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 2
- 101100075927 Aspergillus aculeatus mndA gene Proteins 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 229910021580 Cobalt(II) chloride Inorganic materials 0.000 description 2
- 229910021592 Copper(II) chloride Inorganic materials 0.000 description 2
- 108020004414 DNA Proteins 0.000 description 2
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 2
- 101100022282 Escherichia coli O157:H7 manC2 gene Proteins 0.000 description 2
- 101150102398 Galt gene Proteins 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 239000004098 Tetracycline Substances 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 101100168102 Yersinia pseudotuberculosis colC gene Proteins 0.000 description 2
- FZIVHOUANIQOMU-YIHIYSSUSA-N alpha-L-Fucp-(1->2)-beta-D-Galp-(1->3)-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H]([C@H](O[C@@H]4[C@H](OC(O)[C@H](O)[C@H]4O)CO)O[C@H](CO)[C@@H]3O)O)O[C@H](CO)[C@H]2O)NC(C)=O)O[C@H](CO)[C@H](O)[C@@H]1O FZIVHOUANIQOMU-YIHIYSSUSA-N 0.000 description 2
- CMQZRJBJDCVIEY-JEOLMMCMSA-N alpha-L-Fucp-(1->3)-[beta-D-Galp-(1->4)]-beta-D-GlcpNAc-(1->3)-beta-D-Galp-(1->4)-D-Glcp Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)[C@@H](CO)O[C@@H](O[C@@H]2[C@H]([C@H](O[C@@H]3[C@H](OC(O)[C@H](O)[C@H]3O)CO)O[C@H](CO)[C@@H]2O)O)[C@@H]1NC(C)=O CMQZRJBJDCVIEY-JEOLMMCMSA-N 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- AXQLFFDZXPOFPO-FSGZUBPKSA-N beta-D-Gal-(1->3)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc Chemical compound O([C@@H]1O[C@H](CO)[C@H](O)[C@@H]([C@H]1O)O[C@H]1[C@@H]([C@H]([C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O1)O)NC(=O)C)[C@H]1[C@H](O)[C@@H](O)C(O)O[C@@H]1CO AXQLFFDZXPOFPO-FSGZUBPKSA-N 0.000 description 2
- PTVXQARCLQPGIR-SXUWKVJYSA-N beta-L-fucose 1-phosphate Chemical compound C[C@@H]1O[C@H](OP(O)(O)=O)[C@@H](O)[C@H](O)[C@@H]1O PTVXQARCLQPGIR-SXUWKVJYSA-N 0.000 description 2
- 238000013375 chromatographic separation Methods 0.000 description 2
- 230000002759 chromosomal effect Effects 0.000 description 2
- 238000003776 cleavage reaction Methods 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- 230000001419 dependent effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 101150041441 fcl gene Proteins 0.000 description 2
- 101150002054 galE gene Proteins 0.000 description 2
- 101150045500 galK gene Proteins 0.000 description 2
- 101150054547 galM gene Proteins 0.000 description 2
- 210000001035 gastrointestinal tract Anatomy 0.000 description 2
- 238000001641 gel filtration chromatography Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 101150106565 gmd gene Proteins 0.000 description 2
- 230000010354 integration Effects 0.000 description 2
- 239000013067 intermediate product Substances 0.000 description 2
- 101150001899 lacY gene Proteins 0.000 description 2
- FZIVHOUANIQOMU-UHFFFAOYSA-N lacto-N-fucopentaose I Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(OC3C(C(OC4C(OC(O)C(O)C4O)CO)OC(CO)C3O)O)OC(CO)C2O)NC(C)=O)OC(CO)C(O)C1O FZIVHOUANIQOMU-UHFFFAOYSA-N 0.000 description 2
- 229940062780 lacto-n-neotetraose Drugs 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 101150088678 manB gene Proteins 0.000 description 2
- 101150032120 manC gene Proteins 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- RBMYDHMFFAVMMM-PLQWBNBWSA-N neolactotetraose Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@H](O[C@H]([C@H](O)CO)[C@H](O)[C@@H](O)C=O)O[C@H](CO)[C@@H]1O)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O RBMYDHMFFAVMMM-PLQWBNBWSA-N 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 239000002417 nutraceutical Substances 0.000 description 2
- 235000021436 nutraceutical agent Nutrition 0.000 description 2
- 239000013612 plasmid Substances 0.000 description 2
- 108091033319 polynucleotide Proteins 0.000 description 2
- 102000040430 polynucleotide Human genes 0.000 description 2
- 239000002157 polynucleotide Substances 0.000 description 2
- 229920001184 polypeptide Polymers 0.000 description 2
- 235000013406 prebiotics Nutrition 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 230000001902 propagating effect Effects 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 229960002180 tetracycline Drugs 0.000 description 2
- 229930101283 tetracycline Natural products 0.000 description 2
- 235000019364 tetracycline Nutrition 0.000 description 2
- 150000003522 tetracyclines Chemical class 0.000 description 2
- 241001515965 unidentified phage Species 0.000 description 2
- VEZMRVFFWXRVTR-REJJGIIRSA-N (2S,3S,4S,5R,6R)-6-(hydroxymethyl)-2-[(2R,3R,4S,5R)-4,5,6-trihydroxy-2-(hydroxymethyl)-4-[(3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxan-3-yl]oxy-3-[(3S,4R,5S,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxane-3,4,5-triol Chemical compound C1([C@@H](O)[C@H](O)[C@H](O)[C@@H](O1)C)[C@]1([C@H](C(O)O[C@@H]([C@H]1O[C@H]1[C@](O)([C@@H](O)[C@@H](O)[C@H](O1)CO)C1[C@@H](O)[C@H](O)[C@H](O)[C@@H](O1)C)CO)O)O VEZMRVFFWXRVTR-REJJGIIRSA-N 0.000 description 1
- 229940062827 2'-fucosyllactose Drugs 0.000 description 1
- HWHQUWQCBPAQQH-UHFFFAOYSA-N 2-O-alpha-L-Fucosyl-lactose Natural products OC1C(O)C(O)C(C)OC1OC1C(O)C(O)C(CO)OC1OC(C(O)CO)C(O)C(O)C=O HWHQUWQCBPAQQH-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- AUNPEJDACLEKSC-ZAYDSPBTSA-N 3-fucosyllactose Chemical compound O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O)[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)O[C@H](CO)[C@@H]1O AUNPEJDACLEKSC-ZAYDSPBTSA-N 0.000 description 1
- WJPIUUDKRHCAEL-UHFFFAOYSA-N 3FL Natural products OC1C(O)C(O)C(C)OC1OC1C(OC2C(C(O)C(O)C(CO)O2)O)C(CO)OC(O)C1O WJPIUUDKRHCAEL-UHFFFAOYSA-N 0.000 description 1
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- TXCIAUNLDRJGJZ-UHFFFAOYSA-N CMP-N-acetyl neuraminic acid Natural products O1C(C(O)C(O)CO)C(NC(=O)C)C(O)CC1(C(O)=O)OP(O)(=O)OCC1C(O)C(O)C(N2C(N=C(N)C=C2)=O)O1 TXCIAUNLDRJGJZ-UHFFFAOYSA-N 0.000 description 1
- TXCIAUNLDRJGJZ-BILDWYJOSA-N CMP-N-acetyl-beta-neuraminic acid Chemical compound O1[C@@H]([C@H](O)[C@H](O)CO)[C@H](NC(=O)C)[C@@H](O)C[C@]1(C(O)=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(N=C(N)C=C2)=O)O1 TXCIAUNLDRJGJZ-BILDWYJOSA-N 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 206010007733 Catabolic state Diseases 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- 101710121765 Endo-1,4-beta-xylanase Proteins 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical class OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- FZHXIRIBWMQPQF-UHFFFAOYSA-N Glc-NH2 Natural products O=CC(N)C(O)C(O)C(O)CO FZHXIRIBWMQPQF-UHFFFAOYSA-N 0.000 description 1
- 102000005744 Glycoside Hydrolases Human genes 0.000 description 1
- 108010031186 Glycoside Hydrolases Proteins 0.000 description 1
- 108700023372 Glycosyltransferases Proteins 0.000 description 1
- TVVLIFCVJJSLBL-SEHWTJTBSA-N Lacto-N-fucopentaose V Chemical compound O[C@H]1C(O)C(O)[C@H](C)O[C@H]1OC([C@@H](O)C=O)[C@@H](C(O)CO)O[C@H]1[C@H](O)[C@@H](OC2[C@@H](C(OC3[C@@H](C(O)C(O)[C@@H](CO)O3)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](O)[C@@H](CO)O1 TVVLIFCVJJSLBL-SEHWTJTBSA-N 0.000 description 1
- 241000186610 Lactobacillus sp. Species 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 101100536300 Pasteurella multocida (strain Pm70) talB gene Proteins 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 238000005273 aeration Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- NPPRJALWPIXIHO-PNCMPRLYSA-N beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-[beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->6)]-beta-D-Gal-(1->4)-D-Glc Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)OC[C@@H]1[C@@H]([C@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O[C@H]3[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O3)O)[C@@H](CO)O2)NC(C)=O)[C@@H](O)[C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)O1)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O NPPRJALWPIXIHO-PNCMPRLYSA-N 0.000 description 1
- IEQCXFNWPAHHQR-YKLSGRGUSA-N beta-D-Gal-(1->4)-beta-D-GlcNAc-(1->3)-beta-D-Gal-(1->4)-D-Glc Chemical compound O([C@H]1[C@H](O)[C@H]([C@@H](O[C@@H]1CO)O[C@@H]1[C@H]([C@H](O[C@@H]2[C@H](OC(O)[C@H](O)[C@H]2O)CO)O[C@H](CO)[C@@H]1O)O)NC(=O)C)[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O IEQCXFNWPAHHQR-YKLSGRGUSA-N 0.000 description 1
- 230000001588 bifunctional effect Effects 0.000 description 1
- 229920001222 biopolymer Polymers 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000001013 cariogenic effect Effects 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 238000003889 chemical engineering Methods 0.000 description 1
- 238000007385 chemical modification Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000008260 defense mechanism Effects 0.000 description 1
- 239000013530 defoamer Substances 0.000 description 1
- 239000007857 degradation product Substances 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000003831 deregulation Effects 0.000 description 1
- 238000010612 desalination reaction Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000006911 enzymatic reaction Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 239000012527 feed solution Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000005417 food ingredient Substances 0.000 description 1
- 229930182479 fructoside Natural products 0.000 description 1
- 235000013376 functional food Nutrition 0.000 description 1
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 1
- 150000003271 galactooligosaccharides Chemical class 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- 229930182470 glycoside Natural products 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 230000013595 glycosylation Effects 0.000 description 1
- 238000006206 glycosylation reaction Methods 0.000 description 1
- 102000045442 glycosyltransferase activity proteins Human genes 0.000 description 1
- 108700014210 glycosyltransferase activity proteins Proteins 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 108010064833 guanylyltransferase Proteins 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000007407 health benefit Effects 0.000 description 1
- 244000052637 human pathogen Species 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 230000028993 immune response Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000028709 inflammatory response Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 229930193965 lacto-N-fucopentaose Natural products 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- WMYQZGAEYLPOSX-JOEMMLBASA-N lex-lactose Chemical compound OC1[C@@H](O)[C@@H](O)[C@@H](C)O[C@@H]1O[C@H]1C(O[C@H]2[C@@H](C(O)C(O)C(CO)O2)O)[C@@H](CO)O[C@@H](O[C@@H]2[C@H]([C@H](OC(C(O)CO)[C@H](O)[C@@H](O)C=O)OC(CO)C2O)O)C1NC(C)=O WMYQZGAEYLPOSX-JOEMMLBASA-N 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 235000002867 manganese chloride Nutrition 0.000 description 1
- 230000001404 mediated effect Effects 0.000 description 1
- 244000005706 microflora Species 0.000 description 1
- 238000010369 molecular cloning Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000020939 nutritional additive Nutrition 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000007017 scission Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 230000001839 systemic circulation Effects 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000026683 transduction Effects 0.000 description 1
- 238000010361 transduction Methods 0.000 description 1
- 238000001890 transfection Methods 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229920001221 xylan Polymers 0.000 description 1
- 150000004823 xylans Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/26—Preparation of nitrogen-containing carbohydrates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/14—Preparation of compounds containing saccharide radicals produced by the action of a carbohydrase (EC 3.2.x), e.g. by alpha-amylase, e.g. by cellulase, hemicellulase
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H1/00—Processes for the preparation of sugar derivatives
- C07H1/06—Separation; Purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- C12N15/72—Expression systems using regulatory sequences derived from the lac-operon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/12—Disaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P19/00—Preparation of compounds containing saccharide radicals
- C12P19/20—Preparation of compounds containing saccharide radicals produced by the action of an exo-1,4 alpha-glucosidase, e.g. dextrose
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/10—Plasmid DNA
- C12N2800/101—Plasmid DNA for bacteria
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Virology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13183670.2A EP2845905B8 (en) | 2013-09-10 | 2013-09-10 | Production of oligosaccharides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2875327T3 true ES2875327T3 (es) | 2021-11-10 |
Family
ID=49117764
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES13183670T Active ES2875327T3 (es) | 2013-09-10 | 2013-09-10 | Producción de oligosacáridos |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11427845B2 (enExample) |
| EP (3) | EP3572520A1 (enExample) |
| JP (3) | JP6894703B2 (enExample) |
| KR (1) | KR102335067B1 (enExample) |
| CN (5) | CN110643658A (enExample) |
| AU (1) | AU2014320757C1 (enExample) |
| BR (1) | BR112016005228A8 (enExample) |
| DK (1) | DK2845905T3 (enExample) |
| ES (1) | ES2875327T3 (enExample) |
| PL (1) | PL2845905T3 (enExample) |
| WO (1) | WO2015036138A1 (enExample) |
Families Citing this family (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK2845905T3 (da) * | 2013-09-10 | 2021-06-14 | Chr Hansen Hmo Gmbh | Fremstilling af oligosaccharider |
| DK2896628T3 (en) | 2014-01-20 | 2019-01-14 | Jennewein Biotechnologie Gmbh | Process for Effective Purification of Neutral Milk Oligosaccharides (HMOs) from Microbial Fermentation |
| DK3277287T3 (da) | 2015-03-31 | 2024-01-08 | Glycom As | Blandinger af humane mælke-oligosaccharider, der omfatter 3 '-o-sialyllactose |
| US10829508B2 (en) | 2015-12-18 | 2020-11-10 | Glycom A/S | Fermentative production of oligosaccharides |
| DE202017007248U1 (de) | 2016-04-19 | 2020-04-23 | Glycom A/S | Abtrennung von Oligosacchariden aus der Fermentationsbrühe |
| CN119523994A (zh) | 2016-06-24 | 2025-02-28 | 格礼卡姆股份公司 | 包括hmo的组合物、其制备和用于预防和/或治疗病毒和/或细菌感染的用途 |
| CN106190938B (zh) * | 2016-07-18 | 2019-05-14 | 南开大学 | 一种构建的重组大肠杆菌及生物合成3’-唾液乳糖的方法 |
| CN109715169A (zh) * | 2016-07-28 | 2019-05-03 | 方塔拉合作集团有限公司 | 乳制品和工艺 |
| EP3515195A4 (en) * | 2016-09-19 | 2020-05-27 | Prolacta Bioscience, Inc. | COMPOSITIONS OF PURIFIED HUMAN MILK OLIGOSACCHARIDES |
| PL3315610T3 (pl) * | 2016-10-29 | 2021-06-14 | Jennewein Biotechnologie Gmbh | Sposób wytwarzania fukozylowanych oligosacharydów |
| WO2018130630A1 (en) | 2017-01-13 | 2018-07-19 | Chr. Hansen A/S | Process for producing a fermented milk product |
| JP2018140968A (ja) * | 2017-02-28 | 2018-09-13 | 日本食品化工株式会社 | １，６−アンヒドロ−β−Ｄ−グルコフラノース含有糖質の製造方法 |
| EP3375291B1 (en) | 2017-03-17 | 2022-08-10 | Chr. Hansen HMO GmbH | A method of inhibiting isomerization of a reducing saccharide upon thermal treatment |
| EP3645545A4 (en) | 2017-06-30 | 2021-05-05 | Glycom A/S | PURIFICATION OF OLIGOSACCHARIDES |
| EP3425052A1 (en) | 2017-07-07 | 2019-01-09 | Jennewein Biotechnologie GmbH | Fucosyltransferases and their use in producing fucosylated oligosaccharides |
| CN110914284B (zh) | 2017-07-12 | 2025-01-07 | 格礼卡姆股份公司 | 包含中性单糖或寡糖和酸性非碳水化合物组分的无定形混合物 |
| ES3039971T3 (en) | 2017-12-08 | 2025-10-28 | Chr Hansen Hmo Gmbh | Spray-dried 3-fucosyllactose |
| PL3494806T3 (pl) | 2017-12-08 | 2025-10-06 | Chr. Hansen HMO GmbH | Suszona rozpyłowo lakto-n-fukopentaoza |
| WO2019110800A1 (en) | 2017-12-08 | 2019-06-13 | Jennewein Biotechnologie Gmbh | Spray-dried mixture of human milk oligosacchrides |
| ES3039685T3 (en) | 2017-12-08 | 2025-10-23 | Chr Hansen Hmo Gmbh | Spray-dried tetrasaccharides |
| EP3494807A1 (en) | 2017-12-11 | 2019-06-12 | Jennewein Biotechnologie GmbH | Spray-dried sialyllactose |
| DK3524067T3 (da) | 2018-02-08 | 2025-05-19 | Chr Hansen Hmo Gmbh | Spraytørret blanding af modermælksoligosaccharider |
| SG11202010729XA (en) | 2018-05-07 | 2020-11-27 | Jennewein Biotechnologie Gmbh | A SIMPLE METHOD FOR THE PURIFICATION OF LACTO-N-NEOTETRAOSE (LNnT) FROM CARBOHYDRATES OBTAINED BY MICROBIAL FERMENTATION |
| EP3569713A1 (en) * | 2018-05-16 | 2019-11-20 | Jennewein Biotechnologie GmbH | Use of glycosidases in the production of oligosaccharides |
| KR20210013138A (ko) * | 2018-05-23 | 2021-02-03 | 디에스엠 아이피 어셋츠 비.브이. | 올리고당의 제조 |
| US10519475B1 (en) * | 2018-11-21 | 2019-12-31 | Amyris, Inc. | Biosynthesis of compounds in yeast |
| CN113226506B (zh) * | 2018-12-19 | 2023-05-12 | 格礼卡姆股份公司 | 寡糖的分离 |
| CN109735479B (zh) * | 2019-01-30 | 2022-04-01 | 光明乳业股份有限公司 | 一种合成2’-岩藻糖基乳糖的重组枯草芽孢杆菌及其构建方法与应用 |
| EP4012026A4 (en) * | 2019-05-21 | 2023-11-15 | Korea University Research and Business Foundation | USE OF AN ENZYME; THAT CLIPS BOTH ALPHA-ACE AND BETA-1,4-GLYCOSIDIIC BONDS |
| ES2963307T3 (es) * | 2019-06-04 | 2024-03-26 | Nutricia Nv | Composición nutricional que comprende 2'-fucosil-lactosa y 3'-galactosil-lactosa |
| US20220330584A1 (en) | 2019-09-04 | 2022-10-20 | Dupont Nutrition Biosciences Aps | Process for removing an antifoam agent from a solution comprising a human milk oligosaccharide and related compositions |
| WO2021061991A1 (en) | 2019-09-24 | 2021-04-01 | Prolacta Bioscience, Inc. | Compositions and methods for treatment of inflammatory and immune diseases |
| US12479878B2 (en) | 2020-03-12 | 2025-11-25 | Glycom A/S | Crystallization of 2′-FL |
| BR112023002758A2 (pt) | 2020-08-14 | 2023-05-02 | Prolacta Bioscience Inc | Composições de oligossacarídeos de leite humano para uso com bacterioterapias |
| EP4277634A1 (en) | 2021-01-12 | 2023-11-22 | Prolacta Bioscience, Inc. | Synbiotic treatment regimens |
| DK181562B1 (en) * | 2021-11-11 | 2024-05-17 | Dsm Ip Assets Bv | Feed control system for a fermentation system, and related method |
| DK181566B1 (en) | 2021-12-21 | 2024-05-24 | Dsm Ip Assets Bv | Crystallization of LNnT |
| CN114107342B (zh) * | 2021-12-27 | 2024-01-26 | 黄山同兮生物科技有限公司 | 一种去除发酵液中乳糖的方法 |
| KR102616020B1 (ko) | 2021-12-31 | 2023-12-22 | 매일유업 주식회사 | 모유 올리고당 혼합물을 유효성분으로 포함하는 장관면역 개선용, 장 염증 예방 또는 개선용 조성물 |
| CN116042562B (zh) * | 2022-03-11 | 2023-10-20 | 山东恒鲁生物科技有限公司 | 重组酵母菌及其应用 |
| CN115011535A (zh) * | 2022-05-10 | 2022-09-06 | 南通励成生物工程有限公司 | 一种以葡萄糖为碳源合成2’-岩藻糖基乳糖的菌株及其构建方法和应用 |
| KR20240002283A (ko) * | 2022-06-28 | 2024-01-05 | 주식회사 삼양사 | 2’-푸코실락토오스 제조방법 |
| CN120018780A (zh) | 2022-08-25 | 2025-05-16 | 帝斯曼知识产权资产管理有限公司 | 生产复杂hmo的混合方法 |
| EP4623089A1 (en) | 2022-11-25 | 2025-10-01 | DSM IP Assets B.V. | Two-strain system for producing oligosaccharides |
| WO2024130119A2 (en) | 2022-12-16 | 2024-06-20 | Prolacta Bioscience, Inc. | Synbiotic compositions for short chain fatty acid production |
| WO2025114343A2 (en) | 2023-11-29 | 2025-06-05 | Frieslandcampina Nederland B.V. | Process for the production of human milk oligosaccharides |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5995895A (ja) * | 1982-11-22 | 1984-06-02 | Meiji Seika Kaisha Ltd | フラクトオリゴ糖の精製法 |
| JPS6391092A (ja) | 1986-10-07 | 1988-04-21 | Yakult Honsha Co Ltd | オリゴ糖の製造法 |
| JPH0695895A (ja) | 1990-11-19 | 1994-04-08 | Internatl Business Mach Corp <Ibm> | アプリケーシヨンプログラム装置及びその方法 |
| JPH05276969A (ja) * | 1992-04-03 | 1993-10-26 | Nippon Shinyaku Co Ltd | 高純度マルトオリゴ糖の製法 |
| JPH07274990A (ja) * | 1994-04-15 | 1995-10-24 | Mitsubishi Kasei Eng Co | 環状イヌロオリゴ糖の精製方法 |
| JP3095643B2 (ja) * | 1994-11-17 | 2000-10-10 | 明治製菓株式会社 | 高濃度糖混合液からの高純度オリゴ糖類の製造法 |
| JP4238028B2 (ja) * | 2000-11-16 | 2009-03-11 | 株式会社林原生物化学研究所 | α−イソマルトシル転移酵素活性を有するポリペプチド |
| US20080145899A1 (en) * | 2004-09-17 | 2008-06-19 | Neose Technologies Inc | Production of Oligosaccharides By Microorganisms |
| EP2135094B1 (en) | 2007-04-16 | 2017-03-08 | Momenta Pharmaceuticals, Inc. | Characterization of n-glycans using exoglycosidases |
| KR100945306B1 (ko) | 2007-12-31 | 2010-03-03 | 주식회사 삼양제넥스 | 고순도 갈락토올리고당의 제조방법 |
| JP5455244B2 (ja) * | 2008-03-12 | 2014-03-26 | タタ ケミカルズ リミテッド | 遊離細胞によるガラクトオリゴ糖の製造方法 |
| US20110300584A1 (en) | 2008-12-19 | 2011-12-08 | Jennewein Biotechnologie Gmbh | Synthesis of fucosylated compounds |
| EP2440661B1 (en) * | 2009-06-08 | 2017-12-06 | Jennewein Biotechnologie GmbH | Hmo synthesis |
| IT1395068B1 (it) * | 2009-08-07 | 2012-09-05 | Inalco Spa | Processo per la produzione di galatto-oligosaccaridi ultrapuri |
| CN101870992A (zh) * | 2010-06-21 | 2010-10-27 | 天津科技大学 | 利用基因工程菌耦合发酵合成gdp-岩藻糖的方法 |
| DK2439264T3 (en) | 2010-10-11 | 2015-08-03 | Jennewein Biotechnologie Gmbh | Novel fucosyltransferases and their use |
| ES2439507T3 (es) | 2011-01-20 | 2014-01-23 | Jennewein Biotechnologie Gmbh | Fucosiltransferasas novedosas y sus aplicaciones |
| CA2827313C (en) * | 2011-02-16 | 2023-08-22 | Glycosyn LLC | Biosynthesis of human milk oligosaccharides in engineered bacteria |
| BR112013029208A2 (pt) * | 2011-05-13 | 2017-02-14 | Glycom As | método para preparar um ou mais oligossarídeos de leite humano ou derivados ou precursores dos mesmos, uso de oligossacarídeos, e, composto |
| EP2728009B1 (en) * | 2012-10-31 | 2017-07-26 | Jennewein Biotechnologie GmbH | Process for producing monosaccharides |
| DK2845905T3 (da) * | 2013-09-10 | 2021-06-14 | Chr Hansen Hmo Gmbh | Fremstilling af oligosaccharider |
-
2013
- 2013-09-10 DK DK13183670.2T patent/DK2845905T3/da active
- 2013-09-10 EP EP19184573.4A patent/EP3572520A1/en active Pending
- 2013-09-10 PL PL13183670T patent/PL2845905T3/pl unknown
- 2013-09-10 EP EP13183670.2A patent/EP2845905B8/en active Active
- 2013-09-10 EP EP19184576.7A patent/EP3572521A1/en active Pending
- 2013-09-10 ES ES13183670T patent/ES2875327T3/es active Active
-
2014
- 2014-07-04 KR KR1020167008748A patent/KR102335067B1/ko active Active
- 2014-07-04 CN CN201910957839.7A patent/CN110643658A/zh active Pending
- 2014-07-04 AU AU2014320757A patent/AU2014320757C1/en active Active
- 2014-07-04 CN CN202410094161.5A patent/CN118028397A/zh active Pending
- 2014-07-04 BR BR112016005228A patent/BR112016005228A8/pt not_active Application Discontinuation
- 2014-07-04 CN CN201480061563.XA patent/CN105722991A/zh active Pending
- 2014-07-04 CN CN201910957609.0A patent/CN110628842A/zh active Pending
- 2014-07-04 JP JP2016541849A patent/JP6894703B2/ja active Active
- 2014-07-04 WO PCT/EP2014/064280 patent/WO2015036138A1/en not_active Ceased
- 2014-07-04 CN CN202410094021.8A patent/CN118028396A/zh active Pending
-
2016
- 2016-03-10 US US15/067,037 patent/US11427845B2/en active Active
-
2019
- 2019-08-23 JP JP2019152702A patent/JP7389584B2/ja active Active
- 2019-08-23 JP JP2019152682A patent/JP6992029B2/ja active Active
-
2022
- 2022-07-22 US US17/814,337 patent/US12123040B2/en active Active
- 2022-07-22 US US17/814,333 patent/US11981947B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN110643658A (zh) | 2020-01-03 |
| US11427845B2 (en) | 2022-08-30 |
| EP3572520A1 (en) | 2019-11-27 |
| CN105722991A (zh) | 2016-06-29 |
| BR112016005228A2 (enExample) | 2017-09-05 |
| US12123040B2 (en) | 2024-10-22 |
| CN118028396A (zh) | 2024-05-14 |
| DK2845905T3 (da) | 2021-06-14 |
| JP6992029B2 (ja) | 2022-01-13 |
| JP7389584B2 (ja) | 2023-11-30 |
| CN110628842A (zh) | 2019-12-31 |
| JP2019213552A (ja) | 2019-12-19 |
| KR102335067B1 (ko) | 2021-12-03 |
| US20220389468A1 (en) | 2022-12-08 |
| US11981947B2 (en) | 2024-05-14 |
| US20160186223A1 (en) | 2016-06-30 |
| AU2014320757B2 (en) | 2018-04-19 |
| WO2015036138A1 (en) | 2015-03-19 |
| KR20160065111A (ko) | 2016-06-08 |
| AU2014320757A1 (en) | 2016-04-28 |
| EP2845905A1 (en) | 2015-03-11 |
| BR112016005228A8 (pt) | 2022-11-08 |
| PL2845905T3 (pl) | 2021-09-27 |
| JP6894703B2 (ja) | 2021-06-30 |
| EP2845905B1 (en) | 2021-05-19 |
| EP2845905B8 (en) | 2021-07-14 |
| AU2014320757C1 (en) | 2018-07-19 |
| EP3572521A1 (en) | 2019-11-27 |
| CN118028397A (zh) | 2024-05-14 |
| JP2019213553A (ja) | 2019-12-19 |
| JP2016530888A (ja) | 2016-10-06 |
| US20220403433A1 (en) | 2022-12-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2875327T3 (es) | Producción de oligosacáridos | |
| CN111172220B (zh) | 寡糖的发酵生产 | |
| EP2927316B1 (en) | Total fermentation of oligosaccharides | |
| EP2728009B1 (en) | Process for producing monosaccharides | |
| HK40016913A (en) | Production of oligosaccharides | |
| HK40016916A (en) | Production of oligosaccharides |